Executive Advisory Board
Myriad Venture PartnersCheck size: Myriad does not publish a standard person-specific check range; it launched with $100M in initial commitments.
Kim Branson is listed in a Executive Advisory Board capacity at Myriad Venture Partners. The firm does not publish a person-specific investment thesis for this role; the profile therefore preserves the role distinction and uses the firm's public mandate only as shared context.
AI-first enterprise products, vertical applications, data and compute infrastructure, autonomous factories, resilient supply chains and clean industrial systems.
No formal pass list is public. Consumer-only opportunities or businesses without enterprise, AI or industrial transformation relevance appear less aligned.
Show the enterprise pain, AI or data advantage, early customer proof, industry transformation potential and the exact corporate relationships that could accelerate adoption.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Kim Branson is listed by Myriad Venture Partners as Executive Advisory Board. Chief AI Officer at GSK.